MQS-10729-09642
2 vaccinations
4 coded responses
24 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 024 / MA
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Dose 1 — Pfizer-BioNTech
-
2021-01-30
Registered in v-safe
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
-
2021-02-15
Survey response — day 14, dose 1MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
-
2021-02-25
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throat since yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Survey response — day 7, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-21
- 2021-08-20
-
2022-02-19
Survey response — 12 months, dose 2MedDRA: Haemorrhage, Heavy menstrual bleeding, Retinal detachment, Retinal operation, Uterine dilation and curettage — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Very heavy menstrual bleeding; Detached retina · Healthcare visit (other): DNC for bleeding; out-patient laser of retinaMedDRA releases: 2024-11 · check-in free text available
-
2022-02-19
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-22
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-19 | Successful 2022-02-22 |
Participant prefers to complete VAERS report online |
Free text
Release 4 — day 14, dose 1
Symptoms: Sore throat
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat since yesterday
Release 4 — day 7, dose 2
Systemic reaction (other): Sore throat
Release 11 — 12 months, dose 2
Symptoms: Very heavy menstrual bleeding; Detached retina
Healthcare visit (other): DNC for bleeding; out-patient laser of retina
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Haemorrhage | · | · | ✓ |
| HCVO | Retinal operation | · | · | ✓ |
| HCVO | Uterine dilation and curettage | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Retinal detachment | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release